Lenvatinib with everolimus for previously treated advanced renal cell carcinoma: Technology appraisal guidance [TA498] – NICE

Evidence-based recommendations on lenvatinib (Kisplyx) with everolimus for previously treated advanced renal cell carcinoma in adults.

Ceritinib for untreated ALK-positive non-small-cell lung cancer: Technology appraisal guidance [TA500] – NICE

Evidence-based recommendations on ceritinib (Zykadia) for untreated anaplastic lymphoma kinase (ALK)-positive non-small-cell lung cancer in adults.

Screening Quality Assurance visit report NHS Bowel Cancer Screening Programme: North East London Bowel Cancer Screening Centre

Executive summary of quality assurance (QA) visit to North East London Bowel Cancer Screening Centre held on 17 March 2017.  The QA visit team identified 9 high priority findings as summarised below: Barts Health NHS Trust does not have an agreed

Cancer in Kent and Medway – Public Health England

Kent and Medway Cancer Alliance Report that aims to give care providers and policy makers an insight into the burden of cancer – measured in terms of the number of people affected, deaths and survival. They also comment on some

Cancer in Thames Valley – Public Health England

Thames Valley Cancer Alliance Report that aims to give care providers and policy makers an insight into the burden of cancer – measured in terms of the number of people affected, deaths and survival. They also comment on some identified

Cancer in Surrey and Sussex – Public Health England

Surrey And Sussex Cancer Alliance Report that aims to give care providers and policy makers an insight into the burden of cancer – measured in terms of the number of people affected, deaths and survival. They also comment on some

Cancer in Wessex – Public Health England

Wessex Cancer Alliance Report that aims to give care providers and policy makers an insight into the burden of cancer – measured in terms of the number of people affected, deaths and survival. They also comment on some identified risk

Reducing avoidable hospital based care: re-thinking out of hospital clinical pathways – South East Clinical Senate

Improving health outcomes, preventing serious illness, providing convenient, timely and cost effective care, and avoiding the unnecessary use of acute hospitals, is a shared goal across the NHS, and requires a radical re-think about how and where care is delivered,

Lung cancer clinical outcomes publication 2017 (for surgical operations performed in 2015) – Royal College of Physicians and The Society for Cardiothoracic Surgery in Great Britain and Ireland

The clinical outcomes publication is an NHS England initiative, commissioned by the Healthcare Quality Improvement Partnership (HQIP), to publish quality measures at unit level and the level of individual consultant doctor using national clinical audit and administrative data. The following

National Prostate Cancer Audit: Annual Report 2017 Results of the NPCA Prospective Audit in England and Wales for men diagnosed from 1 April 2015 – 31 March 2016 – National Prostate Cancer Audit

National Prostate Cancer Audit annual report presenting national demographic information on patients diagnosed with prostate cancer, key aspects of the diagnostic and staging process they underwent and treatments received.  It describes variation in disease presentation across providers and presents performance

NHS efficiency map: redesigning services: Enhanced supportive cancer care – Healthcare Financial Management Association

Case study of the transformation of existing palliative care services into enhanced supportive care (ESC). . The multi-disciplinary ESC team covered all patients’ needs. It had strong financial support and worked with the oncology team, so that patients could access the ESC team at any stage

National Oesophago-Gastric Cancer Audit Report 2017 – Healthcare Quality Improvement Partnership

This 2017 Annual Report from the National Oesophago-Gastric Cancer Audit provides the most up-to-date information on the care and outcomes of patients diagnosed with OG cancer or oesophageal high grade dysplasia.

Finding the Key to the Cures: A plan to end bowel cancer by 2050 – Bowel Cancer UK

Bowel Cancer UK brought 100 leading scientists, healthcare professionals and people affected by the disease together to identify the key research gaps and priorities in bowel cancer research. If these are addressed, they could transform survival rates and ultimately benefit

Screening Quality Assurance visit report: NHS Breast Screening Programme East Berkshire – Public Health England

Executive summary of quality assurance (QA) visit to the East Berkshire breast screening service held on 5 July 2017. Quality assurance (QA) aims to maintain national standards and promote continuous improvement in screening. This is to ensure that all eligible people have access

The final injustice: variation in end of life care in England – Macmillan Cancer Care

Macmillian Cancer Care report that looks at the experience of cancer patients’ final months and years. It finds that cancer patients approaching the end of their life face repeat emergency visits and the situation is worse for patients who are

Atezolizumab for untreated locally advanced or metastatic urothelial cancer when cisplatin is unsuitable Technology appraisal guidance [TA492] – NICE

Evidence-based recommendations on atezolizumab (Tecentriq) for locally advanced or metastatic urothelial carcinoma in adults. This guidance only includes recommendations for untreated urothelial carcinoma when cisplatin-based chemotherapy is unsuitable. NICE are developing separate guidance for urothelial carcinoma that has progressed after platinum-containing chemotherapy.

Suspected cancer: Quality standard [QS124] – NICE

This quality standard covers the investigation and recognition of suspected cancer, and referral to specialist cancer services for adults, young people and children. It describes high-quality care in priority areas for improvement. In December 2017, the source guidance and definitions

Full team ahead: Understanding the UK Non-Surgical Cancer Treatments Workforce – Cancer Research

Research study commissioned by Cancer Research research study to investigate the non-surgical oncology workforce of the UK. This is the first time UK-wide data has been collected on the non-surgical oncology workforce as a whole and it identifies gaps in the

Cancer Workforce Plan: Phase 1: Delivering the cancer strategy to 2021 – Health Education England

A pragmatic plan from Health Education England to increase the net supply of numbers and skills in the short term whilst Health Education England develop a longer-term approach alongside our wider workforce strategy to be published in summer 2018. In addition it

Screening Quality Assurance visit report: NHS Bowel Cancer Screening Programme Bolton – Public Health England

Executive summary of quality assurance (QA) visit in Bolton held on 8 May 2017. Finds 6 high priority findings: backfilled colonoscopy lists need more even distribution to enable all colonoscopists to achieve the minimum standard of 150 procedures per year the